Australian States Could Sue Tobacco Giants for Up to $50bn in Healthcare Costs, Proposal Says

Smoking-related illness places ongoing healthcare burdens on public hospitals and taxpayers, with costs borne by sick smokers and governments.
The industry has not been forced to bear the full costs of the harm
Francey's proposal argues taxpayers and smokers have carried the healthcare costs of tobacco-related disease.
Mark

Why does it matter that this would be a state lawsuit rather than one brought by smokers?

Mimi

Francey's argument is that states using consumer law avoid the hurdles individuals face, like proving which brand caused their illness or fighting the "freedom of choice" defence.

Luke

Though that's his argument. No court has tested it for this purpose.

Mark

What's the $50bn based on?

Mimi

Healthcare costs since 2000, plus money for screening and prevention. Francey says that's justifiable, possibly more.

Luke

It's his estimate. The reporting doesn't show a breakdown, so treat it as a ceiling someone is arguing for, not a calculated bill.

Mark

Are the states on board?

Mimi

Not yet. South Australia is seeking formal advice, NSW will review, Queensland met him but is focused on illicit trade, and WA on legislation and enforcement.

Luke

So one state is formally weighing it. Nobody has committed to sue.

Mark

What do the sceptics say?

Mimi

Liberman says it would need enabling legislation and well-resourced outside law firms, or it could run out of steam. Freeman points to Canada's long case.

Luke

And the tobacco companies' legal response is largely unknown: BAT won't comment, the other two didn't reply.

  • A former barrister's bold proposal would pit six state governments against British American Tobacco, Philip Morris and Imperial Brands in federal court.
  • The claim seeks up to $50bn, a figure that places the cost of smoking-related illness squarely on the companies rather than taxpayers and patients.
  • Governments are split: South Australia has formally sought advice, NSW will review carefully, while Queensland and Western Australia are focused on illicit tobacco and enforcement.
  • Experts warn the path is steep, requiring enabling legislation, deep-pocketed outside firms, and a case that will not collapse under procedural weight or exhausted resources.
  • For now the proposal hangs in the balance, with its fate resting on South Australia's advice and the verdicts of the other states' reviews.

In the quiet machinery of public life, a former barrister who once defended consumers against the tobacco industry's denials is now asking whether Australia's states might turn that old battle into a financial reckoning. Neil Francey proposes that six state governments jointly sue the country's dominant tobacco firms under consumer law for up to $50bn in healthcare costs, arguing that for decades the industry has passed the price of its product onto sick smokers and the public purse. The idea rests on a long memory of corporate concealment, dating to when internal documents revealed what the companies had known, and it now waits on South Australia's legal advice and the cautious reviews of its neighbours.

On Thursday, at the Clinical Oncology Society of Australia's annual scientific meeting in Sydney, Neil Francey laid out a plan that could bring Australia's state governments into federal court against the tobacco industry. He hopes to recover up to $50bn in public healthcare costs, a sum he believes is justified by decades of harm the companies have never fully paid for.

Francey's history with this fight runs deep. In 1991, as a lawyer representing consumers, he took on a federal case sparked by a Tobacco Institute advertisement that denied scientific proof of harm from smoke. The court found that passive smoking causes lung disease in non-smokers, and the ruling helped speed up the workplace and indoor smoking bans that followed. Now his proposal targets British American Tobacco, Philip Morris and Imperial Brands, arguing they can be held liable under consumer law for misleading conduct. The costs sought would stretch back to 2000, the year internal documents showed the companies knew the truth and worked to hide it.

The approach is attractive because it sidesteps the obstacles that often defeat individual smokers, such as proving which brand caused a particular illness. Yet reactions have been measured. South Australia's health minister has formally sought advice on the idea, NSW will review it, and Queensland and Western Australia are focused elsewhere. Health advocates call the idea reasonable, while experts caution that similar cases abroad have taken years and that success here would need specific legislation and strong legal resources.

For now, the proposal remains a question rather than a lawsuit. Its future depends on what South Australia's advice concludes and how the other states respond.

On Thursday, at the Clinical Oncology Society of Australia's annual scientific meeting in Sydney, a former barrister named Neil Francey is laying out a plan that would put Australia's state governments in federal court against the tobacco industry. The aim is to recover up to $50bn in public healthcare costs.

Francey is now a research affiliate with Sydney Health Law. In 1991 he represented consumers in a federal court case set off by a Tobacco Institute of Australia advertisement claiming there was "nothing which proves scientifically" that cigarette smoke causes disease in nonsmokers. The court found compelling scientific proof that passive smoking causes lung disease and respiratory conditions in non-smokers, which made the industry's claims unlawful. The ruling is credited with accelerating bans on smoking in workplaces and public indoor spaces.

His new proposal targets the dominant tobacco companies in Australia, British American Tobacco, Philip Morris and Imperial Brands, along with their overseas parent corporations. It argues they could be held liable under Australian consumer law for decades of misleading and deceptive conduct. The six state governments would pool resources into a joint legal taskforce to run the case. The Northern Territory and the ACT are left out, because the territories are an arm of the commonwealth and differences in healthcare funding could complicate the claim.

The costs sought would run from 2000, the year internal industry documents were published showing the companies knew smoking caused serious disease yet colluded to obscure the evidence. Money would also go toward cancer screening and prevention. "I think you can justify a figure in the order of fifty billion, possibly even more," Francey told Guardian Australia. The proposal argues the industry has never borne the full cost of its product; instead smokers or taxpayers have, when sick people use publicly funded or subsidised care.

Francey says a state-led consumer protection case avoids obstacles that hobble individual smokers' injury suits, where it can be hard to prove which brand caused the harm and companies argue "freedom of choice". States could seek court orders against misleading conduct that has caused loss and damage, and the likelihood of future suffering.

Reactions from governments vary. South Australia's health minister, Blair Boyer, has formally sought advice on the proposal, its likelihood of success and the benefits to South Australians, saying the state must do its own due diligence. NSW says it will review the proposal carefully. Queensland confirmed a meeting with Francey but said its focus is laws against the illicit tobacco and vape trade. Western Australia says it is concentrating on strengthening tobacco legislation and enforcement. BAT Australia does not comment on potential or pending legal claims; Philip Morris and Imperial Brands did not respond.

Laura Hunter, CEO of the Australian Council on Smoking & Health, called it entirely reasonable for the companies to bear the costs of the harm their products caused. Precedents exist abroad: the 1998 Master Settlement Agreement between major US tobacco companies and state attorneys general, and a 2025 Canadian decision ordering three major companies to pay billions, though health groups were disappointed it did not address harms from future use.

Experts urge caution. Becky Freeman, a University of Sydney professor of tobacco control, noted the Canadian case dragged on for years and said any action must stand on "solid ground" to avoid spiralling costs. Jonathan Liberman of the University of Melbourne said US features make large-scale litigation easier there. In Australia, he said, success would need specific enabling legislation and well-resourced outside law firms doing most of the work. Otherwise, suits risk consuming time and public money and failing on procedural grounds or when resources run out.

What happens next depends on South Australia's advice and on the other states' reviews.

I think you can justify a figure in the order of fifty billion, possibly even more.
— Neil Francey
It is important that the state does its own due diligence.
— Blair Boyer, South Australian health minister
Contattaci Domande frequenti